Aspects of quality of care | Incident patients (<90 days) n=258 | Prevalent patients (>6 months) n=258 | p* |
---|---|---|---|
Charlson comorbidity index | 6.4 (2.7) | 6.5 (2.6) | <0.01 |
Adequacy | Paired t-test | ||
Weekly treatment time (min) | 678 (122) | 715 (87) | <0.001 |
Blood flow rate (ml/min) | 294 (67) | 329 (48) | <0.001 |
Treated blood volume (l/kg) | 1.0 (0.3) | 1.1 (0.3) | <0.001 |
HD treatments/week | 3.0 (0.4) | 3.0 (0.3) | NS |
Kt/V | 1.4 (0.5) | 1.5 (0.4) | <0.001 |
URR (%) | 66 (17) | 72 (9) | <0.001 |
Potassium (mmol/l) | 4.8 (0.7) | 5.0 (0.7) | <0.01 |
Nutrition | |||
Body weight | 70.8 (20) | 71.6 (18.6) | NS |
BMI (kg/m2) | 25.9 (6.5) | 25.9 (5.8) | NS |
Albumin (g/l) | 36.6 (4.6) | 42 (3.4) | <0.01 |
Anemia | |||
Hb (g/dl) all pts | 9.8 (1.5) | 10.7 (1.4) | <0.001 |
Hb (g/dl) on ESA | 9.8 (1.4) | 10.6 (1.3) | <0.001 |
TSAT (%) | 26 (12) | 30 (13) | 0.001 |
Ferritin (μg/l) | 331 (330) | 458 (507) | <0.001 |
Weekly ESA dose (IU/week) | 5243 (4221) | 4627 (4347) | 0.092 |
ERI (EPO IU/week/kg/Hb) | 8.2 (7.3) | 5.5 (5.8) | 0.05 |
CKD MBD | |||
Phosphorus (mg/dl) | 4.8 (1.6) | 5.0 (1.7) | 0.084 |
Calcium (mg/dl) | 8.5 (1.3) | 8.6 (1.2) | <0.05 |
iPTH (pg/ml) | 389 (316) | 348 (305) | 0.005 |
Blood pressure | |||
MAP (mm Hg) | 95 (12) | 95 (12) | NS |
IDBWG (%) | 1.8 (1.3) | 1.9 (6.0) | NS |
UF volume (ml/session) | 1611 (934) | 1964 (986) | <0.001 |
Vascular access | Percent | Percent | McNemars test |
AV fistula (%) | 35 | 55 | <0.001 |
AV graft (%) | 1 | 2 | NS |
CVC (%) | 64 | 42 | <0.001 |